Phreesia’s Q4 Results Review
<p>Analysts at RBC Capital provided their view on <a href='https://financialmodelingprep.com/financial-summary/PHR'>Phreesia, Inc. (NYSE:PHR)</a> following the company’s recently reported Q4 results. While EPS of ($0.90) came in worse than the consensus estimate of ($0.85), revenue of $58 million beat the consensus estimate of $56.29 million.</p>
<p>The company’s 2023 guidance was mixed, but for the longer term the analysts are incrementally more encouraged the company will be able to maintain its market-leading position given the better-than-expected Q4 revenue/client adds and additional detail management provided around its longer-range revenue/EBITDA outlooks. </p>
<p>Notably, the company is now targeting a 30% revenue CAGR through 2025 (vs. 20-25% before) at which point it also expects to approach EBITDA profitability.</p>

NYSE:PHR